Zinger Key Points
- Intuitive Surgical plans to acquire da Vinci and Ion distribution businesses in Southern Europe, expected to close in 2026.
- CEO Gary Guthart emphasizes the importance of direct presence in Italy, Spain, Portugal, Malta, and San Marino to better serve customers.
- Get the Real Story Behind Every Major Earnings Report
On Tuesday, Intuitive Surgical, Inc. ISRG announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories.
The acquisition, subject to regulatory approvals, will expand Intuitive’s direct presence in these regions, with the transaction expected to close in 2026.
Intuitive has entered into an agreement with its current distributors, ab medica, Abex, and Excelencia Robotica, to purchase their Intuitive product-related business.
Once the deal is finalized, the acquired businesses will be fully integrated into Intuitive’s European operations, led by Senior Vice President and General Manager Dirk Barten.
CEO Gary Guthart expressed excitement about the opportunity to bring minimally invasive care to more patients across Europe. He highlighted the importance of having a direct presence in these countries to better understand the unique needs of customers.
“Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries,” Guthart added.
Francesca Cerruti, CEO of ab medica, emphasized their long history of introducing robotic-assisted surgery in Southern Europe.
According to Benzinga Pro, ISRG stock has gained over 62% in the past year. Investors can gain exposure to the stock via Spinnaker ETF Series Langar Global HealthTech ETF LGHT.
Price Action: ISRG shares are trading higher by 1.03% to $610.33 at last check Wednesday.
Read Next:
Photo via Shutterstock.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.